The FDA has informed us that some stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc., are being sold in the U.S. market. They may not have been stored and handled properly, and may be dangerous for patients to use. The agency is advising patients who use …

Last year at the ADA 68th ADA Scientific Sessions, results from the ACCORD and VADT studies indicated that tight glucose control increased the risk of cardiovascular death. This year they reviewed the results again and found that the headlines were unfounded. Now they have reversed their opinions and are saying …

Lower hemoglobin A1c levels alone don’t appear to increase mortality risk with intensive glucose control, subanalyses of two major diabetes trials revealed. Each 1% lower average HbA1c was associated with a 56% lower relative risk of mortality. Diabetes patients had reduced composite cardiovascular event and mortality rates with intensive glucose …

Researchers at the ADA reported that Liraglutide reverses prediabetes indices in most obese patients with existing prediabetes …Full Story

Once-weekly exenatide (EQW) produces superior improvements in glucose control and body weight compared with maximum daily doses of sitagliptin and pioglitazone on background metformin, according to study results presented at the American Diabetes Association (ADA) 69th Scientific Sessions.

The findings of two 52-week studies show that the investigational ultra rapid acting insulin AFRESA® (insulin human [rDNA origin]) Inhalation Powder combined with basal insulin is comparable to standard of care therapies in controlling post-meal blood sugar levels, and also results in significantly less weight gain and risk of hypoglycemia …

Retrospective Cohort Study included more than 25,000 BYETTA patients accrued over three years … Full Story

Three investigational diet drugs hold promise for preventing and treating diabetes. The findings show that the drugs can help “halt the progression towards Type 2 diabetes.

We are back from the 69th ADA Scientific Sessions and there were a lot of new studies, practice pearls and products in development. We have stocked this weeks issue with some of the early highlights and will have more over the next few weeks as our editorial staff has time …

ADA confirms that the A1c test will be used for the diagnosis of diabetes. Fasting blood sugar tests will no longer be necessary to diagnosis diabetes. The A1c test can be done anytime without regard to meals. ADA – International Expert Committee Recommends A1c Test to Diagnose Diabetes